Global Stem Cell Anticancer Therapeutics Market 2012-2016
Global
Stem Anticancer Therapeutics market to grow at a CAGR of 11.48 percent over the
period 2012-2016. Increasing investment in R&D is one of the key factors
contributing to this market growth. The Global Stem Anticancer Therapeutics
market has also been witnessing an increasing number of strategic alliances
among vendors. However, stringent regulatory approval processes could pose a
challenge to the growth of this market.
To Read The Complete Report with
TOC:-
Global
Stem Anticancer Therapeutics Market 2012-2016, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers
the market in the Americas, and the EMEA and APAC regions; it also covers the
Global Stem Anticancer Therapeutics market landscape and its growth prospects
in the coming years. The report also includes a discussion of the key vendors
operating in this market.
The
key vendors dominating this space include Celgene Corp., Curis Inc., Exelixis
Inc., Gamida Cell Ltd., Lonza Group, Merck & Co. Inc., OncoMed
Pharmaceuticals Inc., Pfizer Inc., Roche Holding AG, Teva Pharmaceutical
Industries Ltd., and Verastem Inc.
To Buy a Copy Of This Report:-
Key
questions answered in this report:
·
What will the
market size be in 2016 and what will be the growth rate?
·
What are key
market trends?
·
What is driving
this market?
·
What are the
challenges to market growth?
·
Who are the key
vendors in this market space?
·
What are the
market opportunities and threats faced by key vendors?
·
What are the
strengths and weaknesses of each of these key vendors?
Contact:-
M/s
Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948